Epidemiological Features of CKD in Taiwan

American Journal of Kidney Diseases

Volumn 49, Issue 1, 2007, Pages 46-55

  Kuo, Hsin Wei ^a   Tsai, Shang Shyue ^a   Tiao, Mao Meng ^a   Yang, Chun Yuh ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease (CKD); incidence; Prevalence; risk factor

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INFANT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEWBORN; RISK FACTOR; TAIWAN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INCIDENCE; INFANT; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; TAIWAN;

EID: 33845587954     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.10.007     Document Type: Article

References (37)

1. Lysaght M.J. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13 suppl 1 (2002) S37-S40
2. Xue J.L., Ma J.Z., Louis T.A., and Collins A.J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12 (2001) 2753-2758
3. The National Institutes of Health. US Renal Data System: USRDS 2005 Annual Data Report (2005), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
4. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
5. Hwang S.J., Yang W.C., and Dialysis Surveillance Committee of Taiwan Society of Nephrology (TSN). National dialysis surveillance in Taiwan-1999. Acta Nephrol 14 (2000) 139-169. http://www.tsn.org.tw Available at: www.tsn.org.tw. Accessed June 30, 2006
6. Bureau of National Health Insurance: National Health Insurance Annual Statistical Report (2000), ROC, Department of Health, Executive Yuan, Taiwan. http://www.doh.gov.tw/statistic/index.htm Available at: www.doh.gov.tw/statistic/index.htm. Accessed June 30, 2006
7. National Insurance Research Database (2004), National Health Research Institute, Taipei, Taiwan. http://www.nhri.org.tw/nhird Available at: www.nhri.org.tw/nhird. Accessed June 30, 2006
8. Chinese Hospital Association. ICD-9-CM English-Chinese Dictionary (2000), Chinese Hospital Association Press, Taipei, Taiwan
9. Hillege H.L., Janssen W.M., Bak A.A., and PREVEND Study Group. Microalbuminuria is common, also in a non-diabetic, non-hypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 249 (2001) 519-526
10. Magnason R.L., Indridason O.S., Sigvaldason H., Sigfusson N., and Palsson R. Prevalence and progression of CRF in Iceland: A population-based study. Am J Kidney Dis 40 (2002) 955-963
11. Ramirez S.P., McClellan W., Port F.K., and Hsu S.I. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 13 (2002) 1907-1917
12. Chadban S.J., Briganti E.M., and Kerr P.G. Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study. J Am Soc Nephrol 14 suppl 2 (2003) S131-S138
13. Iseki K. The Okinawa screening program. J Am Soc Nephrol 14 suppl 2 (2003) S127-S130
14. Li P.K., Kwan B.C., Leung C.B., et al. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl 94 (2005) S36-S40
15. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
16. Schaeffner E.S., Kurth T., Curhan G.C., et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14 (2003) 2084-2091
17. Domrongkitchaiporn S., Sritara P., Kitiyakara C., et al. Risk factors for development of decreased kidney function in a southeast Asian population: A 12-year cohort study. J Am Soc Nephrol 16 (2005) 791-799
18. Nissenson A.R., Pereira B.J., Collins A.J., and Steinberg E.P. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 37 (2001) 1177-1183
19. Amato D., Alvarez-Aguilar C., Castaneda-Limones R., et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl 97 (2005) S11-S17
20. Clase C.M., Garg A.X., and Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13 (2002) 1338-1349
21. Levey A.S., Greene T., Kusek J.W., Beck G.J., and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A (abstr)
22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
23. Foley R.N., Murray A.M., Li S., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16 (2005) 489-495
24. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
25. The Renal Association: UK Renal Registry: The Seventh Annual Report. Available at: www.renalreg.com/. Accessed June 30, 2006
26. Silbiger S.R., and Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25 (1995) 515-533
27. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
28. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
29. Jafar T.H., Schmid C.H., Landa M., et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135 (2001) 73-87
30. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
31. Parving H.H., Lehnert H., Brochner-Mortensen J., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 (2001) 870-878
32. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59 (2001) 260-269
33. Tonelli M., Moye L., Sacks F.M., Kiberd B., Curhan G., and Cholesterol and Recurrent Events (CARE) Trial Investigators. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138 (2003) 98-104
34. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (2002) 974-980
35. Reis S.E., Olson M.B., Fried L., et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 105 (2002) 2826-2829
36. Collins A.J., Li S., Gilbertson D.T., Liu J., Chen S.C., and Herzog C.A. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 87 (2003) S24-S31
37. Trivedi H.S., Pang M.M., Campbell A., and Saab P. Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives. Am J Kidney Dis 39 (2002) 721-729